Addus HomeCare Corporation (NASDAQ:ADUS) Given Consensus Recommendation of “Moderate Buy” by Analysts

Addus HomeCare Corporation (NASDAQ:ADUS) has received an average recommendation of “Moderate Buy” from the eleven ratings firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $131.2222.

A number of research analysts have issued reports on the stock. Royal Bank Of Canada restated an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research note on Wednesday, February 25th. KeyCorp restated an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday, February 25th. Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. Barclays cut their price target on shares of Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating on the stock in a research note on Friday, May 15th. Finally, Citizens Jmp restated a “market outperform” rating and set a $142.00 price target on shares of Addus HomeCare in a research note on Monday.

Addus HomeCare Trading Up 1.3%

NASDAQ ADUS opened at $93.76 on Friday. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.08. The firm has a market cap of $1.75 billion, a PE ratio of 17.33, a price-to-earnings-growth ratio of 1.27 and a beta of 0.92. The company has a 50 day moving average price of $96.10 and a 200 day moving average price of $105.73. Addus HomeCare has a 52 week low of $89.76 and a 52 week high of $124.43.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, May 4th. The company reported $1.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.52 by $0.10. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The business had revenue of $363.50 million for the quarter, compared to analyst estimates of $366.41 million. During the same quarter in the prior year, the business posted $1.42 EPS. Addus HomeCare’s revenue for the quarter was up 7.7% compared to the same quarter last year. As a group, sell-side analysts forecast that Addus HomeCare will post 6.24 EPS for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In other news, EVP David W. Tucker sold 704 shares of the stock in a transaction on Tuesday, February 24th. The shares were sold at an average price of $107.35, for a total value of $75,574.40. Following the sale, the executive vice president owned 10,802 shares in the company, valued at $1,159,594.70. This represents a 6.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Brian Poff sold 2,041 shares of the stock in a transaction on Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total transaction of $218,346.18. Following the completion of the sale, the executive vice president owned 64,512 shares in the company, valued at $6,901,493.76. The trade was a 3.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 16,788 shares of company stock worth $1,785,633 in the last three months. 4.50% of the stock is owned by company insiders.

Institutional Trading of Addus HomeCare

A number of hedge funds and other institutional investors have recently made changes to their positions in ADUS. Royal Bank of Canada increased its stake in shares of Addus HomeCare by 24.3% in the first quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock worth $682,000 after acquiring an additional 1,347 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Addus HomeCare by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock worth $1,026,000 after acquiring an additional 459 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Addus HomeCare by 6.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock worth $5,111,000 after acquiring an additional 2,952 shares during the period. Jane Street Group LLC increased its stake in shares of Addus HomeCare by 387.6% in the first quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock worth $1,092,000 after acquiring an additional 8,780 shares during the period. Finally, Intech Investment Management LLC increased its stake in shares of Addus HomeCare by 44.7% in the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock worth $1,420,000 after acquiring an additional 4,439 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.